Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0000921895-25-000684·Atea Pharmaceuticals, Inc.
Schedule 13D ownership disclosure
Atea Pharmaceuticals Inc
Common Stock, $0.001 par value per share · CUSIP: 04683R106
Event date: 2025-02-27
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Radoff Family FoundationReported CIK 0001496916
Shares: 165,000.00 · Class: 0.2%
- Radoff Bradley LouisReported CIK 0001380585
Shares: 2,820,000.00 · Class: 3.3%
- JEC II Associates, LLCReported CIK 0001477326
Shares: 1,300,000.00 · Class: 1.5%
- The MOS Trust
Shares: 100,000.00 · Class: 0.1%
- MOS PTC, LLC
Shares: 100,000.00 · Class: 0.1%
- Torok MichaelReported CIK 0001967237
Shares: 1,500,000.00 · Class: 1.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-25-000684
- Form type
- SCHEDULE 13D
- Filer
- Atea Pharmaceuticals, Inc.
- CIK
- CIK 1593899
- Filed
- Mar 04, 2025
- Reporting period
- Feb 27, 2025
- Description
- Schedule 13D beneficial ownership